MedTrace Logo

Management of Health-Related QoL Impairment, Including Pain, Depression and Anxiety, in People With Haemophilia A and B

NCT03276130 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2300

Last updated 2024-03-06

No results posted yet for this study

Summary

The puropse of this non-interventional register and survey study is to identify the patterns of prescribed pain, anti-depressive and anti-anxiety medication and management of pain, depression and anxiety for people with haemophilia. The study will be conducted in the Nordic countries (Sweden, Norway, Denmark, Finland) and the aim is to cover the entire haemophilia population in the register part of the study.

Conditions

  • Haemophilia A
  • Haemophilia B

Sponsors & Collaborators

  • Swedish Orphan Biovitrum

    lead INDUSTRY

Eligibility

Min Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-30
Primary Completion
2020-01-30
Completion
2020-01-30

Countries

  • Denmark
  • Finland
  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03276130 on ClinicalTrials.gov